Published in JAMA Internal Medicine · View the paper (DOI)
Researchers found that buprenorphine was associated with a slightly lower risk of malformations overall compared to methadone, with an 18% reduction in relative risk. Both therapies are strongly recommended over untreated opioid use disorder during pregnancy.
Coverage from 2 institutions